Abstract
Amor and colleagues previously developed chimeric antigen receptor (CAR) T cells that can target and eliminate senescent cells. The utility of these senolytic CAR T cells is now expanded to show that they can combat age-related metabolic dysfunction, and that they can be used prophylactically and have effects that persist for months, thus opening the door to the development of long-term senolytic approaches.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 284-286 |
| Number of pages | 3 |
| Journal | Nature Aging |
| Volume | 4 |
| Issue number | 3 |
| DOIs |
|
| State | Published - Mar 2024 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© Springer Nature America, Inc. 2024.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Unleashing CAR T cells to delay metabolic aging'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS